Under The Diaphragm By Stasis Tonga Taste Treatment Hepatitis Cirrhosis Compensatory Period(qi And Blood Stasis) Of Clinical Research

Purpose: Comparing with the Fu zheng hua yu capsule, we observe the traditionalCuban side under the diaphragm by stasis tonga taste treatment hepatitis cirrhosiscompensatory period (qi and blood stasis syndrome) clinical curative effect of observation onliver cirrhosis patients with mild and moderate splenomegaly with bleeding tendency of ease,thereby reducing sudden bleeding risk in patients with cirrhosis, the delay of thecomplications of cirrhosis, for clinical application under the diaphragm by stasis soup providestrong objective data to support modern medicine, and to further study the effect of its relatedimmunological indexes on the liver.Method: In60cases of hepatitis, liver cirrhosis (qi and blood stasis) patients, accordingto the principle of randomized, controlled, divided into the treatment group (under thediaphragm by stasis soup),30cases in the control group30cases. After12weeks of treatment,compared two groups of patients before and after treatment symptoms and signs, routineblood, and clotting tests, liver meritorious service is, digestive colour to exceed and Tlymphocyte subsets CD3, CD4and TGF-beta1indicators of change, and the results werestatistically analyzed.Result: Based on the analysis of curative effect: treatment group total effective rate was90.0%,control group total effective rate was76.7%,the treatment group compared to controlgroup(P<0.05,significant differences,which indicates that under the diaphragm by stasis tongataste treatment of hepatitis,liver cirrhosis (qi and blood stasis) curative effect is superior to theFu zheng hua yu capsule;Two groups of symptoms and signs in traditional Chinese medicine,blood routine (WBC,RBC,PLT),blood coagulation(PT, PTA),liver meritorious service isregular (ALT, AST, GGT, TBIL), digestive colour to exceed (spleen, spleen thick long), liverStiffness value of P <0.05, T lymphocyte subsets (CD4,CD8and CD4/CD8),TGF–β1,P<0.05,all have significant difference, that under the diaphragm effect by stasis tonga taste treatmentgroup is better than the Fu zheng hua yu capsule group. Treatment group before and aftertreatment of TCM symptoms and physical signs, routine blood,and clotting tests,livermeritorious service is, digestive colour to exceed long thick (spleen thick,spleen long, spleenvein and hepatic vein diameter), liver Stiffness values of P <0.05, T lymphocyte subsets (CD4, CD8and CD4/CD8),TGF–β1P<0.05,there are significant differences.Control group beforeand after treatment of TCM symptoms and physical signs, routine blood (WBC, PLT), hepaticfunction (ALT, AST, GGT),digestive colour to exceed(spleen thick,spleen long), liverStiffness value of P values <0.05, TGF–β1P values <0.05, there are significant differences,the two groups of treatment of hepatitis, liver cirrhosis (qi and blood stasis) are effective.Conclusion: Diaphragmatic by stasis tonga taste under the treatment of hepatitis, livercirrhosis (qi and blood stasis) has quickly relieve symptoms, the characteristics of the curativeeffect is distinct. Can effectively reduce the patient’s bleeding tendency, platelets and red andwhite blood cell quantity, long course application has a trend of spleen reduce, the effect ofportal vein pressure reduce, thereby reducing the risk of complications such as bleeding;Improve liver function, reduce the value of liver Stiffness, TGF–β1fibrosis indexes, so it hasgood anti fibrosis effect; Regulate T lymphocyte subsets (CD4, CD8and CD4/CD8), therebyimproving the body immunity, promote the hepatitis virus and balanced immune body, slowdown the process of cirrhosis of the liver, improve the quality of life. Clinical studies haveshown that its curative effect is superior to traditional righting Fu zheng hua yu capsule, and itis safe to use for a long time without side effects, is the treatment of hepatitis, liver cirrhosis(qi and blood stasis) effective Chinese medicine medicinal broth.